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Abstract 1 
Calcium and cAMP are important intracellular modulators involved with the control 2 
of several signaling cascades and functions within cells.  A tight control of these 3 
molecules is necessary to keep normal cell function. Proliferation is one important 4 
function regulated by these second messengers. Here we investigated the effects 5 
of long-term (24 and 48h) incubation with forskolin (10μM), an agonist of adenylate 6 
cyclase, on voltage-dependent Ca2+channel activity using rat GH3 cells. Patch-7 
Clamp experiments revealed a biphasic effect on whole-cell Ca2+ currents. After an 8 
initial decrease when applied acutely, prolonged forskolin treatment induced a 9 
significant increase in total Ca2+ current density. Accordingly, dibutyryl-cAMP 10 
incubation (dbcAMP, 200µM) also showed increase in Ca2+ current density. 11 
However, the maximum effect of dbcAMP occurred only after 72h incubation, 12 
whereas forskolin showed maximal effect earlier (at 48h). FRET- experiments 13 
confirmed that these results were due to elevated intracellular cAMP with forskolin 14 
showing a peak in the first seconds after been applied. In addition, forskolin 15 
resulted in a shift in of the activation threshold of the Ca2+ current by approximately 16 
-7 mV and a fast inactivating component having barium as a charge carrier. 17 
Mibefradil (10µM), but not nickel (50M) inhibited selectively the fast inactivating 18 
current component, indicating that the preferentially up-regulated component was 19 
T-type Ca2+ channels. Further detailed whole-cell Ca2+ current analysis also 20 
suggested an increase in L-type Ca2+ current. We observed that long-term 21 
incubation with forskolin significantly increase cell proliferation. We, then, propose 22 
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that cAMP chronic modulation of voltage-dependent Ca2+ channels promote and 1 
regulate cell proliferation. 2 
   3 
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Introduction  1 
Ca2+ is a ubiquitous intracellular second messenger and it is critical for the regulation 2 
of innumerous cellular processes, including gene expression, apoptosis, cell cycle 3 
and proliferation.  Perturbations in intracellular Ca2+ homeostasis can result in cell 4 
malfunctioning (Carruthers & Suntzeff 1944; Marchi & Pinton 2016; Prevarskaya & 5 
Skryma & Shuba 2010). Therefore, a tight control of Ca2+ mobilization and its 6 
signaling pathways are required for cell survival (Reuter 1983; Reuter & Sigel 1991). 7 
Under resting conditions, intracellular Ca2+ concentration is maintained at 8 
approximately 100nM. Upon stimulation, the intracellular Ca2+ concentration can 9 
increase dramatically, often reaching micro molar levels (Gutnick et al. 1989; Imredy 10 
& Yue 1992; Stern 1992). Such increase occurs via release from intracellular stores 11 
and/or influx through voltage-dependent Ca2+ channels (Perez-Reyes et al. 1998). 12 
Rapid influx of Ca2+ into the cytosol is mediated by voltage-dependent Ca2+ channels 13 
that are usually divided into two groups: high voltage-activated (HVA) and low 14 
voltage-activated (LVA) (Hille 2001). Members of the HVA Ca2+ channels (Cav2.x) 15 
sub-family include L, N, P/Q, and R types typically require stronger membrane 16 
depolarization (>-40 mV) to activate. In contrast, functional LVA Ca2+ channels 17 
(Cav3.x), also called T- type Ca2+ channels, require less membrane depolarization 18 
to activate (~ -60 mV), exhibiting fast current inactivation, slow deactivation 19 
kinetics(Perez-Reyes 2003) and are quite insensitive to the classical organic 20 
(dihydropyridines, benzothiazepines and phenyalkylamines,) and inorganic (Co2+, 21 
Cd2+) blockers (Birnbaumer 1994; Dunlap & Luebke & Turner 1995; Striessnig 1998; 22 
Yunker & McEnery 2003; Díaz 2005) Molecular biology studies have revealed and 23 
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characterized three distinct isoforms: α1G (Cav3.1), α1H (Cav3.2), and α1I (Cav3.3) 1 
(Perez Reyes 2003).  2 
A number of studies have been done to uncover how these Ca2+ channels, HVA and 3 
LVA, are regulated and how they interfere with cell functions (Bers, Lederer & Berlin 4 
1990; Bers 2002; Lory 2006; Mishra & Hermsmeyer 1994; Scherübl, Hescheler & 5 
Riecken 1993; Westenbroek, Ahlijanian & Catterall 1990). One of the most common 6 
pathways for modulation of IcaL amplitude is the β adrenergic receptor/cAMP 7 
signaling cascade resulting in the phosphorylation of L- type calcium channels by 8 
cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) (Asai, 9 
Pelzer & McDonald 1996; Bean 1985; Chad & Eckert 1986; Fu et al. 2014; Hescheler 10 
et al. 1987; Holz, Rane & Dunlap 1986; Minobe et al. 2014; Patriarchi et al. 2016; 11 
Treinys et al. 2016; Xu et al. 2016).  12 
Accordingly, cAMP is involved in cell signalling showing also a large spectrum of 13 
biological functions (Calebiro & Maiellaro 2014; Chin et al. 2002; Filadi & Pozzan 14 
2015; Schwartz 2001).  Crosstalk between cAMP and Ca2+ have been demonstrated 15 
and indicated (Hofer 2012; Siso-Nadal 2009; Vajanaphanich et al. 1995) 16 
homeostasis deregulation affect cell physiology (Déliot & Constantin 2015; Howe 17 
2011) that may result in various diseases (Capiod 2011; Kotturi et al. 2006; Mariot 18 
et al. 2002; Taylor et al. 2008).  19 
Contrasting to the overwhelming data supporting the acute modulation of ion 20 
channel function by cAMP, little is known about how sustained cAMP levels due to 21 
long term exposure affects voltage-dependent Ca2+ currents and if this would 22 
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change cell proliferation rate. We reasoned that exposure time is a very important 1 
parameter and hypothesized that sustained intracellular cAMP bioavailability could 2 
cause relevant changes in the activity of voltage-dependent Ca2+ channels that 3 
would impact cell proliferation rate. 4 
Here, by the first time, we show that long-term exposure to either forskolin elicited a 5 
substantial increase in L- and T-type Ca2+ channel current density and enhanced the 6 
proliferation rate in rat GH3 cells.  7 
 8 
 9 
1. Materials and methods  10 
 11 
1.1. Cell Culture 12 
 13 
GH3 cells (American Type Culture Collection) were cultured in DMEM-HEPES 14 
modification (Sigma-ALDRICH, USA) supplemented with 10% Fetal Bovine Serum 15 
(Cultilab, Brazil). The cells were routinely grown as stocks in 75 cm2 flasks (Costar, 16 
USA) at 37° C in a humidified atmosphere. The culture medium was changed three 17 
times a week. For electrophysiological recordings the cells were sub-cultured on 18 
glass coverslips (Corning, #1, USA) without any pretreatment and plated in 47 mm 19 
dishes. Usually they were used 1-2 days after trypsinization. Forskolin was 20 
prepared as 25 mM stock solution in dimethyl-sulphoxide (DMSO) and added to 21 
the growth medium at a final concentration of 10 μM. Dibutyryl-cAMP (dbcAMP) 22 
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was prepared as 1 mM stock solution in water and added to growth medium to a 1 
final concentration of 200 µM. Cells were exposed to dbcAMP (200 µM) up to 72h 2 
or forskolin (10 μM) for 24 and 48 hours.  3 
 4 
1.2. Electrophysiology 5 
In all experiments the whole-cell mode of the patch-clamp technique was employed 6 
(Hamill 1981). The electrodes were pulled on a PP-83 two-stage (Narishige, 7 
Japan) puller from both soft (1.5 mm non-heparinized micro hematocrit glass 8 
capillaries, Selecta, Brazil) and borosilicate glass capillaries (1.5 mm diameter, 9 
Clark, UK) to a tip diameter of 1-2 μM. The pipette resistance was 2-5 MΩ when 10 
filled with the appropriate pipette solution. 11 
Membrane currents were recorded with a HEKA-EPC 9 amplifier with Pulse and 12 
Pulse-fit acquisition and analysis software (HEKA, Germany). To minimize space-13 
clamp errors, only isolated cells were selected for recording. Cells were not 14 
accepted if the initial seal resistance was < 1.5 GΩ. Voltage errors were minimized 15 
using series resistance compensation (generally 60%). Cancellation of the 16 
capacitance transients and leak subtraction was performed using a programmed 17 
P/4 protocol (Bezanilla & Armstrong 1977) delivered at a particular holding-18 
potential that is appropriate for the measured current. Ba2+ currents (IBa)-voltage 19 
data were typically acquired by recording responses to a consecutive series of step 20 
pulses from a holding potential (-80 mV) with increments of +10 mV for 50 ms. 21 
Data acquisition was initiated approximately 3-5 min after establishment of the 22 
whole-cell configuration when membrane currents had stabilized after intracellular 23 
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dialysis with the pipette solution. Data were always recorded during continuous 1 
perfusion of the clamped cell with extracellular test solution. There were no 2 
corrections for liquid junction potentials. All the experiments were performed at 3 
room temperature (25-28 °C). 4 
Current traces were acquired at 10 kHz and filtered at 2.5 kHz with a 4-pole low-5 
pass Bessel filter. Data analysis was carried out off-line using Pulse-Fit programs 6 
(HEKA, Germany), Excel (Microsoft Office suite, USA) and Sigma Plot v5.0 (Jandel 7 
Scientific, USA). 8 
 9 
 10 
2.3 FRET measurements 11 
GH3 cells were stably transfected with the EPAC-1 cAMP sensor (Nikolaev et al. 12 
2004) For FRET-measurements, cells were seeded on glass-coverslips 2 days 13 
prior to the measurements. Excitation wavelength for FRET-experiments was 436 14 
± 25 nM, emission was splitted at 455 nm (long pass) using a Dual-View beam 15 
splitter, and recorded at 480 ± 15 and 535 ± 20 nm, respectively, with a Cool Snap 16 
HQ2 camera (Photometric). Sample frequency was 0.2 to 0.x Hz to avoid excessive 17 
bleaching. Data acquisition and initial offline analysis was performed with 18 
MetaFluor Software (Molecular Devices). Calculations, final analysis and 19 
representation was done using Excel (Microsoft) and Graph Pad Prism3 (Graph 20 
Pad Software, Inc.). As the EPAC1 cAMP sensor shows decreasing FRET-ratios 21 
with increasing cAMP-concentrations, for convenience the ratios were calculated 22 
as emission at 480 nm (cyan) divided by the emission at 535 nm (yellow). All 23 
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emissions were background subtracted offline. To establish a stable baseline, cells 1 
were initially monitored for 5 to 10 minutes. At the indicated time forskolin (final 2 
concentration 10 µM) or dbcAMP (final concentration 200 µM) was applied. To 3 
evaluate the effect of each drug, the FRET- ratio (Cyan/Yellow) was calculated 4 
before and after each drug application and the difference expressed as FRET ratio-5 
change in % normalized to the baseline. 6 
 7 
2.4 Proliferation 8 
 9 
We use the Real-Time Cell Monitoring (xCELLigence), a highly sensitive system, to 10 
measure cell growth. The xCELLigence system Real-Time Cell Analyzer RTCA-SP 11 
(ACEA Biosciences, USA) is an electrical impedance-based real-time cell 12 
monitoring system for detection of cellular viability (Fig. 2.2). The recording of cell 13 
index values (CI), normalizations and the monitoring of Aβ1-42 mediated 14 
cytotoxicity was performed using RTCA Software 1.2. The RTCA-SP device was 15 
calibrated using RTCA Resistor Plate 96 prior to each experiment and impedance 16 
measurements were carried out in 96-well E-plates (ACEA). The impedance 17 
readout is expressed as arbitrary cell index values. The normalization of cell index 18 
arbitrarily sets cell index to 1 at a desired time point, which is typically the time of 19 
adding compounds. The background impedance caused by the media is measured 20 
using 100ul in each well prior to seeding of cells and is automatically subtracted by 21 
the RTCA software using the following equation: CI – (Ζi – Ζo)/15 with Ζi as the 22 
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impedance at any given time point and Ζo being the background signal (Diemert et 1 
al. 2012). 2 
GH3 were seeded at a density of 5x103/well into 96-well E-plates and left overnight 3 
to allow for cell attachment and left until cell index of reached a value of 1 prior to 4 
addition of forskolin (10µM) and vehicle controls (DMSO) to ensure consistency of 5 
cell number. The resulting data was exported to Microsoft excel using the RTCA 6 
software for further analysis. 7 
 8 
2.5 Solutions 9 
 10 
Patch Clamp: Solutions for whole-cell patch-clamp experiments were designed to 11 
eliminate K+ and Na+ currents and to allow stable Ba2+ currents to be measured. 12 
Ba2+ (Bean 1985; Harraz & Welsh 2013; Li et al. 2010; Nikitina et al. 2007; Perez-13 
Reyes 2003) was used as the charge carrier in all experiments. Cells were first 14 
bathed in regular tyrode solution. After the whole-cell configuration was 15 
established, the external solution was switched to the test solution containing (in 16 
mM): 140 NaCl, 5 CsCl, 5 BaCl2, 5 Glucose, and 0.0003 Tetrodotoxin, and 10 17 
Hepes, pH 7.4 (300-306 mOsm). The pipette (intracellular) solution contained 18 
(mM): 10 NaCl, 130 CsCl, 20 TEACl, 5 EGTA, and 10 Hepes, pH 7.2 (289-291 19 
mOsm).  20 
For FRET experiments extracellular solution was a modified physiological Tyrode 21 
solution containing (in mM): 140 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 15 Glucose, 10 22 
Hepes adjusted to pH 7.2 with NaOH. 23 
 24 
11 
 
2.6 Statistics  1 
All values are given as means ± S.E.M. We evaluated statistical differences using 2 
Student’s unpaired two-tailed t test. We assumed significance when P<0.05.  3 
 4 
3.Results  5 
 6 
Forskolin has biphasic effects on voltage-dependent Ca2+ channels  7 
We used forskolin, a known adenylate cyclase stimulator (Drust & Sutton & Martin 8 
1982; Drust & Martin 1982; Seamon, Padgett & Daly 1981; Seamon & Daly 1981), 9 
in other to increase intracellular cAMP. After 24 or 48 h forskolin incubation, GH3 10 
cells showed significant increase in Ca2+ current density when compared to 11 
controls (Fig.1A). IBa peak were -11.07 ± 1.31 pA/pF for 24h forskolin (72% 12 
increase, n=300), - 9.14 ± 1.18 pA/pF for 48h forskolin (41% increase, n=200), and 13 
-6.44 ± 0.84 pA/pF for control cells (n=200). Conversely, forskolin (10 µM) 14 
provoked a decrease in Ca2+ current density when applied acutely (~1h) to GH3 15 
cells (Data not shown, n=6). No further increase in current density was observed 16 
for longer incubation times (96h, data not shown, n=5).   17 
Under control conditions (no extracellular Ca2+), IBa from control cells inactivates 18 
only very slowly (Figure 1Ai). In contrast, IBa from forskolin-treated cells showed a 19 
clear change in inactivation time-course. There was a slight shift (Figure 1B) 20 
towards hyperpolarized membrane potentials to reach peak current density in 21 
12 
 
forskolin-treated cells. These findings suggest a possible involvement of T-type 1 
Ca2+ channels.  2 
 3 
dbcAMP increases calcium current and mirrors the effect of forskolin 4 
In order to confirm our previous results, we used dbcAMP (a membrane permeable 5 
analogue of cAMP) that is thought to elevate intracellular cAMP levels (Swislocki 6 
1970).  7 
Long-term treatment of cells with dbcAMP increases IBa in a time dependent 8 
manner (Figure 2A).  Contrasting with forskolin results, this increase in peak 9 
current occurred to a greater extent at more positive membrane potentials (> +20 10 
mV) and it was not accompanied by a significant shift in current-voltage 11 
relationship (peak IBa were at –12.0 ± 4.9 mV in control (Figure 2B, n=12), -10.0 ± 12 
2.2 mV in 24 h exposure (Figure 2B, n=17), and –12.7 ± 1.4 mV in 48 h (Figure 2B, 13 
n=11)). On average, the peak current density amplitude at -10 mV increased from -14 
3.9 ± 0.6 pA/pF (Control, n=5) to -8.9 ± 1.1 pA/pF (after 24 h dbcAMP, P<0.05, 15 
n=7) and to -14.1 ± 1.3 pA/pF (after 48 h dbcAMP, P<0.05, n=11) of its control 16 
value (Figure 2C). The observed increase in current density is not related to cell 17 
enlargement (data not shown).  No effect was observed when forskolin-inactive 18 
form (Dideoxi-forskolin) was used (Figure 2D). 19 
 20 
 21 
 22 
 23 
 24 
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Forskolin or dbcAMP increased cAMP in GH3 cells  1 
To confirm if the treatment with forskolin or dbcAMP resulted in intracellular 2 
increase in cAMP, we performed FRET experiments. The treatment with both 3 
drugs (forskolin or dbcAMP) resulted in increase of cAMP with a clear peak 4 
followed by a plateau when forskolin was applied (Figure 3A, black line). The 5 
increase in cAMP due to dbcAMP (Figure 3A, gray line) was much slower and 6 
gradual differently from forskolin. After plateau has been reached (~ 2,000 s) no 7 
significant differences in cAMP levels were further observed.  To exclude 8 
unspecific effects, we also performed control experiments incubating GH3 cells 9 
with DMSO (used as vehicle) and found no changes in cAMP levels.  10 
 11 
L- and T-type voltage-dependent Ca2+ currents are up regulated by cAMP. 12 
So far, our results demonstrate that sustained increase in cAMP levels enhances 13 
voltage-dependent Ca2+ currents in GH3 cells. The kinetics of the current decay 14 
showed fast and slow inactivating components after 24h and 48h forskolin 15 
incubation (Figure 5Ai, ii, and iii). This result strongly suggests the involvement of 16 
L- and T- type Ca2+ channels as targets. To investigate this possibility in more 17 
detail we combined electrophysiological and pharmacological approaches.  18 
To evaluate the contribution of T-type Ca2+ channels in the cells exposed to 19 
forskolin we used Ni2+ as a specific inhibitor (Hagiwara & Takahashi 1967; Harraz 20 
& Welsh 2013; Huguenard 1996; Jeong 2003; Niwa et al. 2004; Nosal et al. 2013) 21 
Figure 4 shows that 50 M Ni2+ partially inhibited Ca2+ currents in GH3 cells 22 
without changes in the inactivation kinetics. It has been demonstrated that some 23 
14 
 
isoforms of the T-type Ca2+ channels are less sensitive to Ni2+ blockade (Díaz et al. 1 
2005; Lacinová, Klugbauer & Hofmann 2000; Lee et al. 1999) we, then, used 2 
mibefradil as a more specific T-type Ca2+ channel organic blocker (Frishman 1997; 3 
Lacinová & Klugbauer & Hofmann 2000; Nikitina et al. 2007; Van der Vring et al. 4 
1999). Mibefradil at 10 µM abolished the fast inactivating component of the Ca2+ 5 
current (Figure 5Aii and 5Aiii, gray area), suggesting that this component is mainly 6 
due to the presence of T-type Ca2+ channels.  7 
We measured currents at the peak (first 5 ms), where both, L and T-type Ca2+ 8 
currents were present, and at the end of the test pulse where only L-type Ca2+ 9 
current was present (Table 1). To calculate the amplitude of the fast inactivating 10 
component of the total IBa current we subtracted the amplitude of the non-11 
inactivating fraction from the peak amplitude. No significant difference was found 12 
when this calculated fraction was compared with the amplitude of the mibefradil 13 
inhibited current (Table 2). This reinforce that T-type Ca2+ channels are responsible 14 
for the fast inactivating current component observed in forskolin treated cells. 15 
To investigate the contribution of L-type Ca2+ currents during forskolin treatment, 16 
we also analysed current amplitudes at the end of the test pulse (Table 3), where 17 
only L-type Ca2+ channels are present. The data clearly show increased L-type 18 
Ca2+ current density in cells treated with forskolin or dbcAMP compared to control 19 
cells.  20 
 21 
 22 
 23 
 24 
15 
 
Long-term treatment with forskolin increased cell proliferation 1 
A large number of investigations have shown the participation of cAMP or calcium 2 
channels in controlling cell proliferation (Lory et al. 2006, Becchetti 2011) . As our 3 
experimental conditions resulted in an increase of cAMP and Ca2+ currents, we 4 
decided to investigate whether cell proliferation were affected.  Our results show a 5 
significant increase in cell proliferation after forskolin treatment and this were more 6 
evident after 24h (Figure 6). 7 
 8 
 9 
3. Discussion 10 
 11 
In this study we have examined the long-term effects of two distinct cAMP 12 
producers, namely dbcAMP and forskolin on voltage-dependent L- and T-type 13 
Ca2+ channels in GH3 cells. Our study provides a number of important points: 1) 14 
dbcAMP and forskolin treatments elevated L- and T-type Ca2+ current densities; 2) 15 
forskolin elicits a fast increase in cAMP levels whereas dbcAMP increases it 16 
slowly; 3) forskolin augments, preferentially, T-type Ca2+ current density; 4) 17 
forskolin treatment elevated Ca2+ currents and stimulated cell proliferation. 18 
The literature about regulation of L-type Ca2+ channels by different protein-kinases 19 
including PKA is vast and more consistent than that for T-type Ca2+ channels.  20 
Experimental evidences indicate that they could be up or down regulated 21 
depending on the cell type and the physiological context where the cells are 22 
inserted (27, 29, 34, 36, 43, 50, 53).  Our results demonstrated that long-term 23 
exposure to cAMP increased L-type Ca2+ current density. Interesting and in 24 
16 
 
agreement with other studies, acute application leads to an opposite effect, 1 
decrease L-type Ca2+ current density. 2 
 There is no clear consensus about the regulation of T-type Ca2+ channels by 3 
PKA, from complete absence to very large effects (Alvarez & Vassort 1992; Bean 4 
1985; Benham & Tsien 1988; Fisher & Johnston 1990; Hagiwara, Irisawa & 5 
Kameyama 1988; Hirano, Fozzard & January 1989; Lenglet 2002; Lory, Bidaud & 6 
Chemin 2006; Tsieng & Boyden 1989; Tytgat et al. 1988). 7 
 The present study demonstrated that forskolin increase T-type Ca2+ current 8 
density by 1.7-fold (24h incubation) and by 1.4-fold (48h incubation).  These results 9 
are partially supported by the study of Giancippoli et al. (2006) and Novara et al. 10 
(2004) who found increased activity of T-type but not L-type Ca2+ channels in rat 11 
chromafin cells when incubated with cAMP or β-adrenergic receptor (-AR) 12 
agonists for 5 days (120h). In addition to that, Mariot et al. (2002) and Rossier et al. 13 
(2003), found an overexpression of T-type Ca2+ channels (specifically the α1H 14 
isoform (CaV3.2)) in differentiating prostate cancer cells when they were treated for 15 
long periods (3-5 days) with dbcAMP or IBMX (non-specific phosphodiesterases 16 
inhibitor). as Choi et al. (2002) demonstrated that T-type Ca2+ currents were 17 
markedly up regulated after sustained β-AR stimulation in cultured cardiomyocytes. 18 
On contrary, Harazz and Welsh (2013) showed that PKA activators suppressed T-19 
Type Ca2+ currents in rat arterial smooth muscle cells. 20 
We reasoned that the opposite results when cAMP is acutely or chronically 21 
incubated might be a strategy of GH3 cells to regulate different functions with the 22 
same molecule. Supporting this proposal, Zaccolo (2007) demonstrated that the 23 
17 
 
final outcome of cAMP signaling cascade could be different even in the same cell 1 
depending on the duration and stimulus localization. 2 
The difference in reaching the maximum response between forskolin and dbcAMP 3 
could be explained by the different time-course in inducing intracellular rise in 4 
cAMP. FRET experiments showed that forskolin generated a fast change in 5 
intracellular cAMP almost immediately after its application which was in contrast 6 
with the very slow change elicited by dbcAMP. Those results reinforce Zaccolo & 7 
Pozzan (2002) where kinetics and location is everything when it comes to  define 8 
which set of components in the cAMP-dependent pathways will be recruited.  9 
Intracellular Ca2+ and its signatures are important factors in controlling cell 10 
proliferation (Capiod 2011). Voltage-dependent Ca2+ channels, such as T-type 11 
Ca2+ channels, are well suited to generate Ca2+ oscillations due to their unique 12 
activation/inactivation properties. 13 
The treatment with forskolin increased cell proliferation rate. Tierney & Robinson 14 
(2002) found that GH3 cells growth was stimulated by cAMP but this was in 15 
contrast with Zivadinovic et al. (2005) where cell growth was attenuated with 16 
increased levels of cAMP. The participation of L- and T-type Ca2+ channels have 17 
been recognized in cell proliferation (Lory, Bidaud & Chemin 2006; Lu et al. 2008, 18 
Mariot et al. 2002).  19 
A plethora of studies points to a role of T-type Ca2+ channels in cell proliferation in 20 
tumors from breast (Artalejo et al. 1990; Reuter & Sigel 1991), brain (Bourinet et al. 21 
1994; Dolphin 1996), colorectal (Eisfeld et al. 1996), gastric (Eisfeld et al. 1996), 22 
leukemic (Eisfeld et al. 1996), prostate (Kaspar & Pelzer 1995; Mori et al. 1993), as 23 
well as in normal vascular smooth muscle cells  (Bezanilla & Armstrong 1977; 24 
18 
 
Hamill et al. 1981;), fibroblast (Zaccolo & Pozzan 2002), neonate ventricular 1 
myocytes (Glassmeier et al. 2001; Yuan & Bers 1995), human myoblasts, and 2 
mouse embryos (Klöckner et al. 1999). In retinoblastoma cells (Fomina, Kostyuk & 3 
Sedova 1993), low proliferation was accompanied by decreased expression of 4 
mRNA for T-type Ca2+ channels and T-type Ca2+ currents. In human myoblasts, 5 
T-type Ca2+ currents are expressed just before fusion and subsequent 6 
differentiation, and their inhibition suppresses fusion and the increase in 7 
intracellular Ca2+ (Fischmeister & Shrier 1989). For Taylor (2008), the fact that 8 
cancer cells expresses T-type Ca2+ channels would provide an altered Ca2+ influx 9 
pathway in response to the increasing demand of Ca2+ during rapid proliferation. 10 
In contrast, Lory et al. (2006) over-expressing both α1H (Cav3.2) and α1G 11 
(Cav3.1) isoforms in neurons observed no evidence of increase in proliferation and 12 
Ohkubo & Yamazaki (2012), suppressed the proliferation over-expressing Cav3.1 13 
in MCF-7 cells.   14 
In summary, we have shown that a coordinated modulation of cAMP and L- and T-15 
type Ca2+ currents induces cell proliferation and suggests that these two signal 16 
pathways may converge at a downstream point to control mitogenesis.  17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
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